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SUMMARY Löfgren’s syndrome is an acute form of sarcoidosis 
that mostly presents with erythema nodosum, periarticular ankle 
inflammation, arthritis, conjunctivitis, and unilateral or bilateral hilar or 
right paratracheal lymphadenopathy. Erythema nodosum is the most 
common cutaneous lesion in acute sarcoidosis, but it is histologically 
nonspecific, as it does not reveal sarcoidal granulomas upon 
microscopic examination. We present a case of a 57-year-old woman 
with acute onset of tender erythematous nodules on the calves, 
which were clinically erythema nodosum-like lesions. Histologic 
analysis revealed sarcoidal granulomas located in the dermis and 
subcutaneous tissue. Upon further work-up, the patient was found 
to have both pulmonary and ocular sarcoidosis. Based on this case, 
we recommend that all patients with erythema nodosum-like lesions 
undergo biopsy and further work-up for sarcoidosis is recommended 
in case of biopsy proven sarcoidal granulomas.
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INTRodUCTIoN
 Löfgren’s syndrome is an acute form of sar-
coidosis, a multysistemic granulomatous disease 
of unknown etiology that has a wide variety of 
clinical manifestations (1). In sarcoidosis, about 
40%-50% of patients have cutaneous involvement 
(2). Cutaneous lesions are divided into specific 
and nonspecific lesions (2,3). Histopathologically, 
specific cutaneous lesions are granulomas, which 
consist of epitheloid macrophages, giant cells and 
a sparse lymphocytic infiltrate, and these may be 
found throughout the dermis and subcutaneous 
tissue (2). 
 Erythema nodosum (EN) is the most nonspe-
cific cutaneous finding and is usually associated 
with acute sarcoidosis and a benign course (4). 
Sarcoidal granulomas in erythema nodosum le-
sions are rare. 
 We present a case of Löfgren’s syndrome and 
EN-like eruption with biopsy proven sarcoidal 
granulomas. 
CASe RePoRT
 A 57-year-old woman presented to Dermatolo-
gy Department for sudden onset of erythematous, 
subcutaneous nodules on the calves (Fig.1), and 
maculopapular rash on the dorsal aspects of the 
feet (Fig. 2). She complained of malaise and chills. 
She denied respiratory difficulties. On examination, 
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she was febrile but free from acute distress. Eye 
examination revealed findings typical of kerato-
conjunctivitis. Laboratory testing revealed a high 
erythrocyte sedimentation rate, elevated liver en-
zymes, serum angiotensin converting enzyme and 
alkaline phosphatase. Antinuclear antibody (ANA), 
antineutrophil cytoplasmic antibody (ANCA) and 
tuberculin skin test were negative. Complement 
levels, serum calcium and 24-h urine calcium lev-
els were also within the normal limits. 
 Histopathology of the nodules showed circum-
scribed granulomas of epitheloid cells throughout 
the dermis with extension into the subcutaneous 
tissue (Fig. 3). Histology of the maculopapular le-
sions showed discrete, round to oval granulomas 
in the superficial dermis (Fig. 4). Mycologic exami-
nation of cutaneous lesions and syphilis serology 
were negative. Chest radiography showed bilater-
al hilar lymphadenopathy (Fig. 5). Total body gal-
lium scan was normal. 
 The patient was treated with 40 mg of pred-
nisone per day for six months. This resulted in 
prompt resolution of cutaneous lesions during the 
first month of therapy. Keratoconjunctivitis was 
treated with local application of steroids.
dISCUSSIoN
 Sarcoidosis is an immune disorder, mediated 
primarily by CD4+ T-helper cells and cells de-
rived from mononuclear phagocytes (5). Immune 
dysregulation has been postulated to be due to a 
persistent antigen of low virulence that is poorly 
cleared by the immune system, which in turn re-
sults in granuloma formation (6).   
 HLA B8, A1 and DR3 have been associated with 
the presence of EN and spontaneous resolution 
of the disease (7). HLA DR17 has been associ-
ated with acute onset of the disease and Löfgren’s 
syndrome (8).
 Sarcoidosis can appear at any age with peaks 
between ages 25-35 and 45-65 (6). The course 
is variable, from a self-limited acute disease to a 
chronic disease that may result in death (9). EN, 
hilar lymphadenopathy, arthralgias and conjuncti-
vitis are signs of acute sarcoidosis, which gener-
ally resolve (2).  
 Löfgren’s syndrome was first recognized as an 
acute, benign form of sarcoidosis by Löfgren and 
Lundback (10,11). Mana et al. describe seasonal 
variation in Löfgren’s syndrome, which usually 
starts in spring (9). Women are more frequently af-
fected than men (2). Patients usually present with 
tender subcutaneous nodules on the anterior tibial 
area, fever, arthralgias, conjunctivitis, and bilateral 
hilar or paratracheal lymphadenopathy (2). Cuta-
neous involvement in sarcoidosis may occur at 
any stage of the disease (12). Cutaneous lesions 
are classified as specific when histologic exami-
nation shows typical sarcoidal granulomas, and 
as nonspecific (2). EN is a nonspecific cutaneous 
finding and has the same clinical and histologic 
appearance as EN lesions of other etiology (13). 
Septal pannicular inflammation is associated with 
some peripheral lobular inflammation as well as 
a superficial and deep dermal lymphocytic inflam-
matory infiltrate (14). Bacterial, fungal and viral 
infections, pregnancy, and malignancies such as 
Hodgkin’s and non-Hodgkin’s lymphoma, leuke-
mia and renal carcinoma have been associated 
with EN (14-17). Autoimmune diseases (Sjögren’s 
syndrome, Reiter’s syndrome, systemic lupus ery-
thematosus, Behçet’s syndrome) can also be un-
derlying conditions (18,19). In adults, the leading 
Figure 1. Erythematous subcutaneous nodules 
on the calves.
Figure 2. Maculopapular rash on the dorsal as-
pects of the feet.
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causes of EN are medications, sarcoidosis, and 
inflammatory bowel disease (20). James reports 
that only two of 170 cases with EN in sarcoidosis 
showed evidence of epitheloid granulomas on his-
tology (21). This rare histologic feature was seen 
in our patient. 
 Cutaneous lesions in the chronic stage tend 
to be more persistent (2,20). Lupus pernio, an-
giolupoid, maculopapular, nodular, plaque, scar, 
ulcerative lesions as well as subcutaneous nod-
ules are examples of specific cutaneous lesions 
(2,20). Multiple forms of clinically atypical granulo-
matous lesions have been described: psoriasiform 
plaques, verrucous and papillomatous lesions, 
ichthyosiform lesions, lichenoid eruptions, cicatri-
cial alopecia, pustular folliculitis and hypopigmen-
tation in black patients (22-28). Biopsy of these 
lesions is diagnostic of sarcoidosis. On the other 
hand, biopsy lesions found in EN are mostly non-
specific (3). 
 In our case, biopsy showed a specific sarcoid 
lesion. Therefore, we believe that skin biopsy 
should be performed in all patients with tender, 
erythematous nodules of lower extremities. Some 
studies examined the relationship of skin sarcoid-
osis with systemic manifestation of the disease 
(3,29,30). Mana et al. report that 27 out of 37 pa-
tients presented initially with specific cutaneous 
lesions, 19 had other systemic manifestation con-
comitantly, whereas 8 who presented with specific 
cutaneous lesions developed systemic manifesta-
tion between 6 months and 3 years later (3). On 
the other hand, skin lesions may also appear later 
in the course of the disease (31). 
 Work-up for systemic manifestations should be 
undertaken in all patients who have biopsy proven 
sarcoidal granulomas of the skin (3). The work-
up should include complete history and physical 
examination, chest radiography, tuberculin skin 
test, ophthalmologic examination, and analysis of 
blood and urine calcium levels and serum angio-
tensin-converting enzyme level (SACE) (3). SACE 
level is elevated in 60% of patients and is help-
ful in monitoring disease activity and therapeutic 
response (3). Computed tomography scanning of 
the thorax and total body gallium scanning may 
be helpful in establishing the diagnosis as well as 
determining the extension of the disease (2,3). 
 Oral corticosteroids are the mainstay of thera-
py in sarcoidosis (2). It should be reserved for se-
vere inflammatory disease of the eye, pulmonary 
and cardiac involvement, central nervous system 
Figure 3. Circumscribed granulomas of epitheloid 
cells throughout the dermis with extension into the 
subcutaneous tissue (hematoxylin-eosin stain; 
original magnification X120).
Figure 4. Histology of maculopapular lesions 
showed discrete, round to oval granulomas in the 
superficial dermis (hematoxylin-eosin stain; origi-
nal magnification X80).
Figure 5. Chest radiography showed bilateral hilar 
lymphadenopathy.
Radoš et al.       Acta Dermatovenerol Croat
Löfgren’s syndrome       2007;15(4):249-253
ACTA DERMATOVENEROLOGICA CROATICA
252 ACTA DERMATOVENEROLOGICA CROATICA
disease and hepatic involvement (2). Alternatives 
to corticosteroids are methotrexate, chlorambu-
cil, azathioprine, cyclophosphamide and thalido-
mide, which can be used in patients refractory to 
or those who develop adverse effects to systemic 
corticosteroids (2). Antimalarials may have immu-
nomodulatory effects and are occasionally used to 
treat cutaneous and pulmonary disease (2). Our 
patient was treated with 40 mg prednisone per day 
for 6 months, as she had the risk of developing 
chronic sarcoidosis. Early withdrawal of therapy is 
coupled with disease relapses, while in rare cases 
therapy is lifelong (32). 
 The course of sarcoidosis is variable. In more 
than 80% of patients with Löfgren’s syndrome, the 
disease resolves spontaneously over two years 
(1). As a general rule, progressive disease is as-
sociated with the presence of specific cutaneous 
lesions (20). In these patients, pulmonary fibrosis 
and neurologic involvement are the most common 
causes of death (2). Follow up care should be fre-
quent for the first two years after diagnosis, but 
our patient could not present for regular control 
visits. 
CoNCLUSIoN
 While EN is the most common nonspecific cu-
taneous lesion of sarcoidosis, the EN-like erup-
tion in our case was a specific sarcoid lesion. 
We conclude that patients with EN-like lesions 
should undergo biopsy. If cutaneous sarcoidal 
granulomas are found, thorough work-up for other 
manifestations of sarcoidosis are recommended. 
Cutaneous sarcoidal granulomas appear to be as-
sociated with a poorer prognosis and an increased 
incidence of pulmonary fibrosis and uveitis. These 
patients should be followed-up carefully.
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